Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...

Ezetimibe is a drug that selectively inhibits cholesterol absorption and further reduces LDL-C when used in addition to statins. The ENHANCE trial is a randomized study aimed at studying the ...

Ezetimibe; Simvastin tablet: Merck has discontinued its cholesterol-lowering combination therapy. These products were expected to be unavailable starting in January. Gadobenate Dimeglumine ...

Ezetimibe reduces LDL cholesterol levels, and niacin raises HDL cholesterol levels; however, no previous studies have described the use of these two drugs in combination. Jelesoff and colleagues ...